A content analysis of direct-to-consumer television prescription drug advertisements

被引:84
|
作者
Kaphingst, KA
DeJong, W
Rudd, RE
Daltroy, LH
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA
[3] Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA
[4] Brigham & Womens Hosp, RBB Arthrit Res Ctr, Boston, MA 02115 USA
关键词
D O I
10.1080/10810730490882586
中图分类号
G2 [信息与知识传播];
学科分类号
05 ; 0503 ;
摘要
This article reports the results of a content analysis of 23 direct-to-consumer (DTC) product-specific television prescription drug advertisements broadcast during 2001. A majority of ads used both medical and lay terms to convey medical ideas. Most gave consumers somewhat more time to absorb facts about benefits than those about risks, which could have implications for the "fair balance'' requirement. Complete references to additional product information were given only in text, casting doubt on whether these ads are making "adequate provision'' for dissemination of detailed product information. Overall, our results call into question the potential of these ads to educate consumers.
引用
收藏
页码:515 / 528
页数:14
相关论文
共 50 条
  • [1] Consumer Understanding of Prescription Drug Indications in Direct-to-Consumer Television Advertisements
    Sullivan, Helen W.
    Aikin, Kathryn J.
    Johnson, Mihaela
    Ferriola-Bruckenstein, Kate
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2025, 59 (02) : 278 - 287
  • [2] An Updated Analysis of Direct-to-Consumer Television Advertisements for Prescription Drugs
    Applequist, Janelle
    Ball, Jennifer Gerard
    ANNALS OF FAMILY MEDICINE, 2018, 16 (03) : 211 - 216
  • [3] Visual images of prescription drug benefits in direct-to-consumer television advertisements
    Sullivan, Helen W.
    O'Donoghue, Amie C.
    Lynch, Molly
    Johnson, Mihaela
    Davis, Christine
    Amoozegar, Jacqueline B.
    Rupert, Douglas J.
    PATIENT EDUCATION AND COUNSELING, 2021, 104 (09) : 2240 - 2249
  • [4] Effect of presentation modality in direct-to-consumer (DTC) prescription drug television advertisements
    Wogalter, Michael S.
    Shaver, Eric F.
    Kalsher, Michael J.
    APPLIED ERGONOMICS, 2014, 45 (05) : 1330 - 1336
  • [5] Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis
    Sullivan, Helen W.
    Aikin, Kathryn J.
    Poehlman, Jon
    HEALTH COMMUNICATION, 2019, 34 (02) : 212 - 219
  • [7] Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements
    Kaphingst, KA
    Rudd, RE
    Dejong, W
    Daltroy, LH
    PATIENT EDUCATION AND COUNSELING, 2004, 55 (02) : 293 - 300
  • [8] Evaluation of Risk Versus Benefit Information in Direct-To-Consumer (DTC) Prescription Drug Television Advertisements
    Fahim, Germin
    Toscani, Michael
    Barone, Joseph A.
    Wang, Chris
    Gandhi, Shivani
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (01) : 114 - 117
  • [9] Evaluation of Risk Versus Benefit Information in Direct-To-Consumer (DTC) Prescription Drug Television Advertisements
    Germin Fahim
    Michael Toscani
    Joseph A. Barone
    Chris Wang
    Shivani Gandhi
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 114 - 117
  • [10] The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements
    Sullivan, Helen W.
    O'Donoghue, Amie C.
    Lynch, Molly
    Johnson, Mihaela
    Davis, Christine
    Rupert, Douglas J.
    MEDICAL DECISION MAKING, 2019, 39 (08) : 975 - 985